These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 8914233)
21. [Evaluation of AUC(0-4) predictive methods for cyclosporine in kidney transplant patients]. Aoyama T; Matsumoto Y; Shimizu M; Fukuoka M; Kimura T; Kokubun H; Yoshida K; Yago K Yakugaku Zasshi; 2005 May; 125(5):441-7. PubMed ID: 15863976 [TBL] [Abstract][Full Text] [Related]
22. Excellent results with high-dose mizoribine combined with cyclosporine, corticosteroid, and basiliximab in renal transplant recipients: multicenter study in Japan. Nishimura K; Uchida K; Yuzawa K; Fukuda Y; Ichikawa Y; Akioka K; Fujisawa M; Sugitani A; Ito S; Nakatani T; Horimi T; Yoshimura N Transplant Proc; 2012 Jan; 44(1):147-9. PubMed ID: 22310601 [TBL] [Abstract][Full Text] [Related]
23. Cyclosporine monitoring in the early post-transplant period in pediatric liver transplant recipients. Frauca E; Diaz MC; de la Vega A; Hierro L; Camarena C; Muñoz Bartolo G; Díez R; Murcia J; Gámez M; Sanchez Peinado C; López Santamaría M; Andrés I; Jara P Pediatr Transplant; 2007 Aug; 11(5):530-5. PubMed ID: 17631022 [TBL] [Abstract][Full Text] [Related]
24. Need for reduction of cyclosporin dosage in renal transplant patients with hypertriglyceridemia but not hypercholesterolemia. Porres FG; Stevenson WC; McCullough C; Pruett TL; Lobo PI; Nezamuddin N Transpl Int; 1996; 9(2):164-7. PubMed ID: 8639260 [TBL] [Abstract][Full Text] [Related]
25. A comparison of the pharmacokinetics of tacrolimus and microemulsified cyclosporin in paediatric renal transplant recipients. Renton KW; Crocker JF; McLellan H; Acott PD Eur J Clin Pharmacol; 2004 Aug; 60(6):421-6. PubMed ID: 15232662 [TBL] [Abstract][Full Text] [Related]
26. Cardiac allograft rejection: do trough cyclosporine levels correlate with the grade of histologic rejection? el Gamel A; Keevil B; Rahman A; Campbell C; Deiraniya A; Yonan N J Heart Lung Transplant; 1997 Mar; 16(3):268-74. PubMed ID: 9087869 [TBL] [Abstract][Full Text] [Related]
27. Comparison of Neoral and Sandimmun for induction and maintenance immunosuppression after kidney transplantation. Senel FM; Yildirim S; Karakayali H; Moray G; Haberal M Transpl Int; 1997; 10(5):357-61. PubMed ID: 9287400 [TBL] [Abstract][Full Text] [Related]
28. Cyclosporin in renal transplantation: a 9 year experience. Yuan ZF; Bailey RR; Gardner J N Z Med J; 1995 Feb; 108(993):29-32. PubMed ID: 7891931 [TBL] [Abstract][Full Text] [Related]
29. Evolution of the therapeutic drug monitoring of cyclosporine. Citterio F Transplant Proc; 2004 Mar; 36(2 Suppl):420S-425S. PubMed ID: 15041378 [TBL] [Abstract][Full Text] [Related]
30. Effects of calcineurin inhibitors on pharmacokinetics of mycophenolic acid and its glucuronide metabolite during the maintenance period following renal transplantation. Naito T; Shinno K; Maeda T; Kagawa Y; Hashimoto H; Otsuka A; Takayama T; Ushiyama T; Suzuki K; Ozono S Biol Pharm Bull; 2006 Feb; 29(2):275-80. PubMed ID: 16462031 [TBL] [Abstract][Full Text] [Related]
31. Evidence for earlier stabilization of cyclosporine pharmacokinetics in de novo renal transplant patients receiving a microemulsion formulation. Kovarik JM; Mueller EA; Richard F; Niese D; Halloran PF; Jeffery J; Paul LC; Keown PA Transplantation; 1996 Sep; 62(6):759-63. PubMed ID: 8824473 [TBL] [Abstract][Full Text] [Related]
32. Study of cyclosporine level at 2 hours after administration in preoperative kidney transplant recipients for prediction of postoperative optimal cyclosporine dose. Sukhavasharin N; Praditpornsilpa K; Avihingsanon Y; Kuoatawintu P; O-Charoen R; Kansanabuch T; Tungsanga K; Eiam-Ong S J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S15-20. PubMed ID: 17044449 [TBL] [Abstract][Full Text] [Related]
34. Effect of gastrointestinal inflammation and age on the pharmacokinetics of oral microemulsion cyclosporin A in the first month after bone marrow transplantation. Schultz KR; Nevill TJ; Balshaw RF; Toze CL; Corr T; Currie CJ; Strong DK; Keown PA Bone Marrow Transplant; 2000 Sep; 26(5):545-51. PubMed ID: 11019845 [TBL] [Abstract][Full Text] [Related]
35. Optimal dose and target trough level in cyclosporine and tacrolimus conversion in renal transplantation as evaluated by lymphocyte drug sensitivity and pharmacokinetic parameters. Takeuchi H; Okuyama K; Konno O; Jojima Y; Akashi I; Nakamura Y; Iwamoto H; Hama K; Iwahori T; Uchiyama M; Ashizawa T; Matsuno N; Nagao T; Hirano T; Oka K Transplant Proc; 2005 May; 37(4):1745-7. PubMed ID: 15919452 [TBL] [Abstract][Full Text] [Related]
36. The value of C2 monitoring in stable renal allograft recipients on maintenance immunosuppression. Einecke G; Mai I; Fritsche L; Slowinski T; Waiser J; Neumayer HH; Budde K Nephrol Dial Transplant; 2004 Jan; 19(1):215-22. PubMed ID: 14671060 [TBL] [Abstract][Full Text] [Related]
37. Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens. Dantal J; Hourmant M; Cantarovich D; Giral M; Blancho G; Dreno B; Soulillou JP Lancet; 1998 Feb; 351(9103):623-8. PubMed ID: 9500317 [TBL] [Abstract][Full Text] [Related]
38. Determination of initial i.v. CYA dosage to achieve target AUC values in pediatric hematopoietic stem cell transplant patients. Jin M; Seto W; Taylor T; Saunders EF; Doyle J; Dupuis LL Bone Marrow Transplant; 2008 Oct; 42(7):455-9. PubMed ID: 18622423 [TBL] [Abstract][Full Text] [Related]
39. Enhanced oral cyclosporine absorption with water-soluble vitamin E early after liver transplantation. Pan SH; Lopez RR; Sher LS; Hoffman AL; Podesta LG; Makowka L; Rosenthal P Pharmacotherapy; 1996; 16(1):59-65. PubMed ID: 8700793 [TBL] [Abstract][Full Text] [Related]
40. Efficacy of area under the curve cyclosporine monitoring in renal transplantation. Meyer MM; Munar M; Udeaja J; Bennett W J Am Soc Nephrol; 1993 Dec; 4(6):1306-15. PubMed ID: 8130357 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]